Cronos Group Inc
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
Market Cap & Net Worth: Cronos Group Inc (CRON)
Cronos Group Inc (NASDAQ:CRON) has a market capitalization of $981.74 Million ($981.74 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #10145 globally and #4750 in its home market, demonstrating a 2.78% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cronos Group Inc's stock price $2.59 by its total outstanding shares 379051102 (379.05 Million).
Cronos Group Inc Market Cap History: 2016 to 2026
Cronos Group Inc's market capitalization history from 2016 to 2026. Data shows growth from $418.02 Million to $981.74 Million (32.88% CAGR).
Index Memberships
Cronos Group Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.02% | #280 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1054 of 3165 |
Weight: Cronos Group Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Cronos Group Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cronos Group Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.16x
Cronos Group Inc's market cap is 5.16 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $418.02 Million | $412.32K | -$885.00K | 1013.81x | N/A |
| 2017 | $2.93 Billion | $3.25 Million | -$1.48 Million | 902.58x | N/A |
| 2018 | $3.94 Billion | $12.12 Million | -$21.64 Million | 324.92x | N/A |
| 2019 | $2.91 Billion | $23.75 Million | $1.17 Billion | 122.41x | 2.49x |
| 2020 | $2.63 Billion | $46.72 Million | -$73.14 Million | 56.31x | N/A |
| 2021 | $1.49 Billion | $64.56 Million | -$396.11 Million | 23.02x | N/A |
| 2022 | $962.79 Million | $86.75 Million | -$168.73 Million | 11.10x | N/A |
| 2023 | $792.22 Million | $87.24 Million | -$73.96 Million | 9.08x | N/A |
| 2024 | $765.68 Million | $117.61 Million | $41.08 Million | 6.51x | 18.64x |
| 2025 | $996.90 Million | $193.36 Million | -$9.45 Million | 5.16x | N/A |
Competitor Companies of CRON by Market Capitalization
Companies near Cronos Group Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Cronos Group Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Cronos Group Inc Historical Marketcap From 2016 to 2026
Between 2016 and today, Cronos Group Inc's market cap moved from $418.02 Million to $ 981.74 Million, with a yearly change of 32.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $981.74 Million | -1.52% |
| 2025 | $996.90 Million | +30.20% |
| 2024 | $765.68 Million | -3.35% |
| 2023 | $792.22 Million | -17.72% |
| 2022 | $962.79 Million | -35.20% |
| 2021 | $1.49 Billion | -43.52% |
| 2020 | $2.63 Billion | -9.52% |
| 2019 | $2.91 Billion | -26.18% |
| 2018 | $3.94 Billion | +34.43% |
| 2017 | $2.93 Billion | +600.87% |
| 2016 | $418.02 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cronos Group Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $981.74 Million USD |
| MoneyControl | $981.74 Million USD |
| MarketWatch | $981.74 Million USD |
| marketcap.company | $981.74 Million USD |
| Reuters | $981.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.